Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person 11-cis-retinol dehydrogenase (RDH5) can reversibly catalyse ...
| Class:Id | Summation:9918441 |
|---|---|
| _displayName | 11-cis-retinol dehydrogenase (RDH5) can reversibly catalyse ... |
| _timestamp | 2024-08-15 16:06:57 |
| created | [InstanceEdit:9918437] Orlic-Milacic, Marija, 2024-08-15 |
| text | 11-cis-retinol dehydrogenase (RDH5) can reversibly catalyse the oxidation of all-trans-retinol (atROL, bound to RLBP1) to all-trans-retinal (atRAL) in retinal pigment epithelium (RPE) cells using NAD+ as cofactor. Defective RDH5 causes retinitis punctata albescens (RPA, also called fundus albipunctatus, FA; MIM:136880). RPA (an autosomal recessive disorder) is a form of stationary congenital night blindness characterised by a reduced regeneration rate of rod and cone photoreceptors and yellow-white lesions within the retina or the RPE. For review, please refer to Zeitz et al. 2015. |
| (summation) | [Pathway:9918438] Defective visual phototransduction due to RDH5 loss of function [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by 11-cis-retinol dehydrogenase (RDH5) can reversibly catalyse ... (9918441)
